Pros | - | - | ||
Cons | - | - |
INDMoney rank | - | - | ||
Category,Subcateogry | Equity,Index Funds | Equity,Index Funds | ||
Fund Age | 0 Years | 1 Years | ||
Fund Size | 11 Cr | 3496 Cr | ||
Min Investment | SIP ₹100 Lumpsum ₹100 | SIP ₹500 Lumpsum ₹500 | ||
Expense Ratio | 0.25% | 0.42% | ||
Exit Load | 0% | 1% | ||
Benchmark Index | Nifty Healthcare TR INR | Nifty India Defence TR INR |
No of Holdings | 22 | 20 | ||
Top 5 Holdings | Sun Pharmaceuticals Industries Ltd (18.25%) Max Healthcare Institute Ltd Ordinary Shares (9.58%) Divi's Laboratories Ltd (8.73%) Cipla Ltd (8.56%) Dr Reddy's Laboratories Ltd (7.89%) | Hindustan Aeronautics Ltd Ordinary Shares (21.12%) Bharat Electronics Ltd (21.06%) Solar Industries India Ltd (14.62%) Mazagon Dock Shipbuilders Ltd (8.88%) Cochin Shipyard Ltd (6.32%) | ||
No of Sectors | 1 | 4 | ||
Top 3 Sectors | Health (100%) | Industrial (79.33%) Basic Materials (15.43%) Tech (4.15%) | ||
Equity % | 97.43% | 100.02% | ||
Debt % | - | - | ||
P/E | 36.58 | 47.96 | ||
P/B | 5.65 | 10.27 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | -0.44% | -3.28% | ||
3-Month Return | - | -14.89% | ||
6-Month Return | - | 41.47% | ||
1-Year Return | - | 6.48% | ||
3-Year Return | - | - | ||
5-Year Return | - | - |
Sharpe | - | - | ||
Alpha | - | - | ||
Beta | - | - | ||
Standard Deviation | - | - | ||
Information Ratio | - | - |
Description | DSP Nifty Healthcare Index Fund Direct Growth is an equity fund.The fund could potentially beat inflation in the long-run. | Motilal Oswal Nifty India Defence Index Fund Direct Growth is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Diipesh Shah,Anil Ghelani | Swapnil Mayekar,Dishant Mehta,Rakesh Shetty |